상단메뉴 바로가기 본문 바로가기 본문 하위메뉴 바로가기 하단 바로가기

News

HOMENews

News

LyseNTech launched a joint research on the development of COVID-19 vaccine with CHA Vaccine Inst.

관리자   /   2020-10-06

 Oct 06, 2020

 

LyseNTech signed an NDA with CHA Vaccine Institute and launched a joint research on the development of phage-based COVID-19 vaccine.

 

CHA Vaccine Institute is a research-oriented biotechnology company focused on the prevention and treatment of infectious diseases as well as chronic disease.